Katty Carola Salinas Flores

Katty Carola Salinas Flores

Auto-generated profile, based on publicly available information

Katty Carola Salinas Flores

PUCE – Hospital Vozandes Quito

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
EFEileen Del Carmen Maurad Farfán
Eileen Del Carmen Maurad Farfán
DODiana Elizabeth Caicedo Oleas
Diana Elizabeth Caicedo Oleas
SZSergio Antonio Villavicencio Zambrano
Sergio Antonio Villavicencio Zambrano
BVByron Fernando Quituisaca Vizhñay
Byron Fernando Quituisaca Vizhñay
KFKatty Carola Salinas Flores
Katty Carola Salinas Flores
Introduction: Thromboangiitis obliterans (TAO) is a non-atherosclerotic inflammatory vasculopathy affecting small and medium-sized vessels, typically in young male smokers, with a significant immune component evidenced by the presence of antineutrophil cytoplasmic antibodies (ANCA) in up to 55-73% of patients (Guo et al., 2013; Halbritter et al., 1998). Overlap with ANCA-associated vasculitis (AAV) is rare but documented (ACP Clinical Cases, 2024). Immune checkpoint inhibitors (ICIs) can trigger fulminant myocarditis, with <1% incidence but high mortality (Vyas et al., 2026). Objective: To synthesize the available evidence on polyvascular TAO, its overlap with AAV, the presence of ANCA, and ICI-induced myocarditis. Methodology: Systematic review following PRISMA 2020 guidelines (Page et al., 2021). A systematic search was conducted in PubMed and other sources for studies published between 1986 and 2026 on TAO, AAV, ANCA and ICI-induced myocarditis. Results: Eight relevant studies were identified. TAO can present with polyvascular involvement, including coronary involvement in 14.3% of cases (Kelemen et al., 2016). AAV-TAO overlap has been documented with positive ANCA and pauci-immune glomerulonephritis (ACP Clinical Cases, 2024). ANCA are present in 55-73% of TAO patients, correlating with disease severity (Guo et al., 2013; Halbritter et al., 1998). ICI-induced myocarditis can present fulminantly, with cardiac biomarker elevation and corticosteroid response (Vyas et al., 2026). Conclusion: Polyvascular TAO represents a destructive paradigm combining thrombotic vascular inflammation, systemic autoimmunity, and immune-mediated myocardial vulnerability, requiring a multidisciplinary diagnostic and therapeutic approach.